NCT03244540

Brief Summary

All patients will be anaesthetized with spinal technique. Each patient will be treated with intravenous morphine - patient controlled analgesia (PCA). 2 of 3 groups of patients will receive ultrasound-guided transversus abdominis plane or quadratus lumborum block to treat postoperative pain. Postoperative pain will measured with visual-analogue scale (VAS). Total morphine consumption and time to the first demand will be noted. 1, 2, 6 months after surgery each patient will be called to assess neuropathic pain with Neuropathic Pain Symptom Inventory (NPSI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Sep 2017

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 9, 2017

Completed
26 days until next milestone

Study Start

First participant enrolled

September 4, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 29, 2018

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2019

Completed
Last Updated

February 18, 2020

Status Verified

February 1, 2020

Enrollment Period

1.2 years

First QC Date

August 4, 2017

Last Update Submit

February 16, 2020

Conditions

Keywords

postoperative paintransversus abdominis plane blockquadratus lumborum blockneuropathic pain

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain measured with VAS

    Acute pain measured with VAS (visual-analogue scale)

    up to 24 hours after surgery

Secondary Outcomes (2)

  • Neuropathic pain assessed with NPSI

    6 months from the surgery

  • Morphine consumption

    up to 24 hours after surgery

Study Arms (3)

PCA

EXPERIMENTAL

Subarchnoid anesthesia with bupivacaine PCA with morphine in the PACU

Drug: ParacetamolProcedure: subarachnoid anesthesiaProcedure: PCA (patient controlled analgesia)Drug: MetamizolDrug: KetoprofenDrug: Bupivacaine

TAP

EXPERIMENTAL

Subarchnoid anesthesia with bupivacaine TAP (transversus abdominis plane block) ultrasound-guided regional block between abdominal wall muscles to treat acute postoperative pain. Stimuplex Ultra 360 needle will be used and 0.375 % ropivacaine administered (0.2 mL/kg) at the and of cesarean section. PCA with morphine in the PACU

Procedure: TAP (transversus abdominis plane block)Device: Stimuplex Ultra 360 needleDrug: RopivacaineDrug: ParacetamolProcedure: subarachnoid anesthesiaProcedure: PCA (patient controlled analgesia)Drug: MetamizolDrug: KetoprofenDrug: Bupivacaine

QLB

EXPERIMENTAL

Subarchnoid anesthesia with bupivacaine QLB (quadratus lumborum block) ultrasound-guided regional block between abdominal wall muscles to treat acute postoperative pain. Stimuplex Ultra 360 needle will be used and 0.375 % ropivacaine administered (0.2 mL/kg) at the and of cesarean section. PCA with morphine in the PACU

Procedure: QLB (quadratus lumborum block)Device: Stimuplex Ultra 360 needleDrug: RopivacaineDrug: ParacetamolProcedure: subarachnoid anesthesiaProcedure: PCA (patient controlled analgesia)Drug: MetamizolDrug: KetoprofenDrug: Bupivacaine

Interventions

ultrasound-guided regional block between abdominal wall muscles to treat acute postoperative pain

TAP

ultrasound-guided regional block between abdominal wall muscles to treat acute postoperative pain

QLB

ultrasound-guided needle will be used for QLB and TAP and regional blocks

QLBTAP

0.375 % ropivacaine will be administered for both QLB and TAP (0.2 mL per kg on both sides)

QLBTAP

Intravenous paracetamol will be used (1.0 gram), up to 4 grams per day

PCAQLBTAP

subarachnoid anesthesia for each patients participating in the study with pencil point needle

PCAQLBTAP

All patients will receive PCA pump with morphine (1 mg/mL, 5 minute interval, no loading dose) after transfer to PACU (post-anesthesia care unit)

PCAQLBTAP

Intravenous metamizol will be used (1.0 gram), up to 4 grams per day

PCAQLBTAP

Intravenous ketoprofen will be used (0.1 gram), up to 200 milligrams per day

PCAQLBTAP

Subarachnoid anesthesia with spinal bupivacaine (MARCAINE SPINAL 0.5% HEAVY)

Also known as: Marcaine
PCAQLBTAP

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • obtained consent
  • singleton pregnancy
  • subarachnoid anaesthesia

You may not qualify if:

  • coagulopathy
  • allergy to morphine and local anesthetics
  • depression, antidepressant drugs treatment
  • epilepsy
  • usage of painkiller before surgery
  • addiction to alcohol or recreational drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Szpital Specjalistyczny PRO-FAMILIA w Rzeszowie

Rzeszów, 35-001, Poland

Location

Szpital Kliniczny Dzieciątka Jezus

Warsaw, 02-005, Poland

Location

Related Publications (3)

  • Kadam VR. Ultrasound-guided quadratus lumborum block as a postoperative analgesic technique for laparotomy. J Anaesthesiol Clin Pharmacol. 2013 Oct;29(4):550-2. doi: 10.4103/0970-9185.119148.

    PMID: 24249997BACKGROUND
  • Kadam VR. Ultrasound guided quadratus lumborum block or posterior transversus abdominis plane block catheter infusion as a postoperative analgesic technique for abdominal surgery. J Anaesthesiol Clin Pharmacol. 2015 Jan-Mar;31(1):130-1. doi: 10.4103/0970-9185.150575. No abstract available.

    PMID: 25788791BACKGROUND
  • Borys M, Zamaro A, Horeczy B, Geszka E, Janiak M, Wegrzyn P, Czuczwar M, Piwowarczyk P. Quadratus Lumborum and Transversus Abdominis Plane Blocks and Their Impact on Acute and Chronic Pain in Patients after Cesarean Section: A Randomized Controlled Study. Int J Environ Res Public Health. 2021 Mar 28;18(7):3500. doi: 10.3390/ijerph18073500.

MeSH Terms

Conditions

Pain, PostoperativeNeuralgia

Interventions

RopivacaineAcetaminophenAnalgesia, Patient-ControlledDipyroneKetoprofenBupivacaine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesAcetanilidesAnalgesiaAnesthesia and AnalgesiaAminopyrinePyrazolonesPyrazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPhenylpropionatesAcids, CarbocyclicCarboxylic Acids

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Participants, care providers, and assessors were not aware of type of the block
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomized 1:1:1
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

August 4, 2017

First Posted

August 9, 2017

Study Start

September 4, 2017

Primary Completion

October 29, 2018

Study Completion

August 30, 2019

Last Updated

February 18, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations